The global Recombinant Hirudin market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
12000ATU/mg Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Hirudin include Abbott, The Medicines Company, Teva Pharmaceutical, Pfizer, Pentapharm, PrimeGene, Aniara Diagnostica, Bioassay Technology Laboratory and Novus Biologicals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Hirudin is the most potent natural inhibitor of thrombin. Unlike antithrombin, hirudin binds to and inhibits only the activity of thrombin, with a specific activity on fibrinogen. Therefore, hirudin prevents or dissolves the formation of clots and thrombi (i.e., it has a thrombolytic activity), and has therapeutic value in blood coagulation disorders, in the treatment of skin hematomas and of superficial varicose veins, either as an injectable or a topical application cream. In some aspects, hirudin has advantages over more commonly used anticoagulants and thrombolytics, such as heparin, as it does not interfere with the biological activity of other serum proteins, and can also act on complexed thrombin.
It is difficult to extract large amounts of hirudin from natural sources, so a method for producing and purifying this protein using recombinant biotechnology has been developed. This has led to the development and marketing of a number of hirudin-based anticoagulant pharmaceutical products. Several other direct thrombin inhibitors are derived chemically from hirudin.
Recombinant Hirudin is derived from yeast and the polypeptide chain contains 65 amino acids and its Mw is 6979.5 Dalton which is identical to natural Hirudin except for the substitution of leucine for isoleucine at the N-terminal end of the molecule and the absence of a sulfate group on the tyrosine at position 63. The Recombinant Hirudin is purified by proprietary chromatographic techniques.
This report aims to provide a comprehensive presentation of the global market for Recombinant Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Hirudin. This report contains market size and forecasts of Recombinant Hirudin in global, including the following market information:
Global Recombinant Hirudin Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Recombinant Hirudin Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Recombinant Hirudin companies in 2023 (%)
We surveyed the Recombinant Hirudin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Hirudin Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Hirudin Market Segment Percentages, by Type, 2023 (%)
12000ATU/mg
16000ATU/mg
Global Recombinant Hirudin Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Hirudin Market Segment Percentages, by Application, 2023 (%)
Thrombosis Disease
Tumor Disease
Global Recombinant Hirudin Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Recombinant Hirudin Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Hirudin revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Recombinant Hirudin revenues share in global market, 2023 (%)
Key companies Recombinant Hirudin sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Recombinant Hirudin sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
The Medicines Company
Teva Pharmaceutical
Pfizer
Pentapharm
PrimeGene
Aniara Diagnostica
Bioassay Technology Laboratory
Novus Biologicals
Merck KGaA
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Hirudin, market overview.
Chapter 2: Global Recombinant Hirudin market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Hirudin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Hirudin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Hirudin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Hirudin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Hirudin Overall Market Size
2.1 Global Recombinant Hirudin Market Size: 2023 VS 2030
2.2 Global Recombinant Hirudin Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Recombinant Hirudin Sales: 2019-2030
3 Company Landscape
3.1 Top Recombinant Hirudin Players in Global Market
3.2 Top Global Recombinant Hirudin Companies Ranked by Revenue
3.3 Global Recombinant Hirudin Revenue by Companies
3.4 Global Recombinant Hirudin Sales by Companies
3.5 Global Recombinant Hirudin Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Recombinant Hirudin Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Recombinant Hirudin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Hirudin Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Hirudin Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Hirudin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Hirudin Market Size Markets, 2023 & 2030
4.1.2 12000ATU/mg
4.1.3 16000ATU/mg
4.2 By Type - Global Recombinant Hirudin Revenue & Forecasts
4.2.1 By Type - Global Recombinant Hirudin Revenue, 2019-2024
4.2.2 By Type - Global Recombinant Hirudin Revenue, 2025-2030
4.2.3 By Type - Global Recombinant Hirudin Revenue Market Share, 2019-2030
4.3 By Type - Global Recombinant Hirudin Sales & Forecasts
4.3.1 By Type - Global Recombinant Hirudin Sales, 2019-2024
4.3.2 By Type - Global Recombinant Hirudin Sales, 2025-2030
4.3.3 By Type - Global Recombinant Hirudin Sales Market Share, 2019-2030
4.4 By Type - Global Recombinant Hirudin Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Hirudin Market Size, 2023 & 2030
5.1.2 Thrombosis Disease
5.1.3 Tumor Disease
5.2 By Application - Global Recombinant Hirudin Revenue & Forecasts
5.2.1 By Application - Global Recombinant Hirudin Revenue, 2019-2024
5.2.2 By Application - Global Recombinant Hirudin Revenue, 2025-2030
5.2.3 By Application - Global Recombinant Hirudin Revenue Market Share, 2019-2030
5.3 By Application - Global Recombinant Hirudin Sales & Forecasts
5.3.1 By Application - Global Recombinant Hirudin Sales, 2019-2024
5.3.2 By Application - Global Recombinant Hirudin Sales, 2025-2030
5.3.3 By Application - Global Recombinant Hirudin Sales Market Share, 2019-2030
5.4 By Application - Global Recombinant Hirudin Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Recombinant Hirudin Market Size, 2023 & 2030
6.2 By Region - Global Recombinant Hirudin Revenue & Forecasts
6.2.1 By Region - Global Recombinant Hirudin Revenue, 2019-2024
6.2.2 By Region - Global Recombinant Hirudin Revenue, 2025-2030
6.2.3 By Region - Global Recombinant Hirudin Revenue Market Share, 2019-2030
6.3 By Region - Global Recombinant Hirudin Sales & Forecasts
6.3.1 By Region - Global Recombinant Hirudin Sales, 2019-2024
6.3.2 By Region - Global Recombinant Hirudin Sales, 2025-2030
6.3.3 By Region - Global Recombinant Hirudin Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Recombinant Hirudin Revenue, 2019-2030
6.4.2 By Country - North America Recombinant Hirudin Sales, 2019-2030
6.4.3 US Recombinant Hirudin Market Size, 2019-2030
6.4.4 Canada Recombinant Hirudin Market Size, 2019-2030
6.4.5 Mexico Recombinant Hirudin Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Hirudin Revenue, 2019-2030
6.5.2 By Country - Europe Recombinant Hirudin Sales, 2019-2030
6.5.3 Germany Recombinant Hirudin Market Size, 2019-2030
6.5.4 France Recombinant Hirudin Market Size, 2019-2030
6.5.5 U.K. Recombinant Hirudin Market Size, 2019-2030
6.5.6 Italy Recombinant Hirudin Market Size, 2019-2030
6.5.7 Russia Recombinant Hirudin Market Size, 2019-2030
6.5.8 Nordic Countries Recombinant Hirudin Market Size, 2019-2030
6.5.9 Benelux Recombinant Hirudin Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Hirudin Revenue, 2019-2030
6.6.2 By Region - Asia Recombinant Hirudin Sales, 2019-2030
6.6.3 China Recombinant Hirudin Market Size, 2019-2030
6.6.4 Japan Recombinant Hirudin Market Size, 2019-2030
6.6.5 South Korea Recombinant Hirudin Market Size, 2019-2030
6.6.6 Southeast Asia Recombinant Hirudin Market Size, 2019-2030
6.6.7 India Recombinant Hirudin Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Recombinant Hirudin Revenue, 2019-2030
6.7.2 By Country - South America Recombinant Hirudin Sales, 2019-2030
6.7.3 Brazil Recombinant Hirudin Market Size, 2019-2030
6.7.4 Argentina Recombinant Hirudin Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Hirudin Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Recombinant Hirudin Sales, 2019-2030
6.8.3 Turkey Recombinant Hirudin Market Size, 2019-2030
6.8.4 Israel Recombinant Hirudin Market Size, 2019-2030
6.8.5 Saudi Arabia Recombinant Hirudin Market Size, 2019-2030
6.8.6 UAE Recombinant Hirudin Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Recombinant Hirudin Major Product Offerings
7.1.4 Abbott Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.1.5 Abbott Key News & Latest Developments
7.2 The Medicines Company
7.2.1 The Medicines Company Company Summary
7.2.2 The Medicines Company Business Overview
7.2.3 The Medicines Company Recombinant Hirudin Major Product Offerings
7.2.4 The Medicines Company Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.2.5 The Medicines Company Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Recombinant Hirudin Major Product Offerings
7.3.4 Teva Pharmaceutical Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Recombinant Hirudin Major Product Offerings
7.4.4 Pfizer Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Pentapharm
7.5.1 Pentapharm Company Summary
7.5.2 Pentapharm Business Overview
7.5.3 Pentapharm Recombinant Hirudin Major Product Offerings
7.5.4 Pentapharm Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.5.5 Pentapharm Key News & Latest Developments
7.6 PrimeGene
7.6.1 PrimeGene Company Summary
7.6.2 PrimeGene Business Overview
7.6.3 PrimeGene Recombinant Hirudin Major Product Offerings
7.6.4 PrimeGene Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.6.5 PrimeGene Key News & Latest Developments
7.7 Aniara Diagnostica
7.7.1 Aniara Diagnostica Company Summary
7.7.2 Aniara Diagnostica Business Overview
7.7.3 Aniara Diagnostica Recombinant Hirudin Major Product Offerings
7.7.4 Aniara Diagnostica Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.7.5 Aniara Diagnostica Key News & Latest Developments
7.8 Bioassay Technology Laboratory
7.8.1 Bioassay Technology Laboratory Company Summary
7.8.2 Bioassay Technology Laboratory Business Overview
7.8.3 Bioassay Technology Laboratory Recombinant Hirudin Major Product Offerings
7.8.4 Bioassay Technology Laboratory Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.8.5 Bioassay Technology Laboratory Key News & Latest Developments
7.9 Novus Biologicals
7.9.1 Novus Biologicals Company Summary
7.9.2 Novus Biologicals Business Overview
7.9.3 Novus Biologicals Recombinant Hirudin Major Product Offerings
7.9.4 Novus Biologicals Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.9.5 Novus Biologicals Key News & Latest Developments
7.10 Merck KGaA
7.10.1 Merck KGaA Company Summary
7.10.2 Merck KGaA Business Overview
7.10.3 Merck KGaA Recombinant Hirudin Major Product Offerings
7.10.4 Merck KGaA Recombinant Hirudin Sales and Revenue in Global (2019-2024)
7.10.5 Merck KGaA Key News & Latest Developments
8 Global Recombinant Hirudin Production Capacity, Analysis
8.1 Global Recombinant Hirudin Production Capacity, 2019-2030
8.2 Recombinant Hirudin Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Hirudin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Hirudin Supply Chain Analysis
10.1 Recombinant Hirudin Industry Value Chain
10.2 Recombinant Hirudin Upstream Market
10.3 Recombinant Hirudin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Hirudin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Hirudin in Global Market
Table 2. Top Recombinant Hirudin Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Recombinant Hirudin Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Recombinant Hirudin Revenue Share by Companies, 2019-2024
Table 5. Global Recombinant Hirudin Sales by Companies, (K Units), 2019-2024
Table 6. Global Recombinant Hirudin Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Recombinant Hirudin Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Hirudin Product Type
Table 9. List of Global Tier 1 Recombinant Hirudin Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Hirudin Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Recombinant Hirudin Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Recombinant Hirudin Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Recombinant Hirudin Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Recombinant Hirudin Sales (K Units), 2019-2024
Table 15. By Type - Global Recombinant Hirudin Sales (K Units), 2025-2030
Table 16. By Application ? Global Recombinant Hirudin Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Recombinant Hirudin Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Recombinant Hirudin Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Recombinant Hirudin Sales (K Units), 2019-2024
Table 20. By Application - Global Recombinant Hirudin Sales (K Units), 2025-2030
Table 21. By Region ? Global Recombinant Hirudin Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Recombinant Hirudin Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Recombinant Hirudin Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Recombinant Hirudin Sales (K Units), 2019-2024
Table 25. By Region - Global Recombinant Hirudin Sales (K Units), 2025-2030
Table 26. By Country - North America Recombinant Hirudin Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Recombinant Hirudin Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Recombinant Hirudin Sales, (K Units), 2019-2024
Table 29. By Country - North America Recombinant Hirudin Sales, (K Units), 2025-2030
Table 30. By Country - Europe Recombinant Hirudin Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Recombinant Hirudin Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Recombinant Hirudin Sales, (K Units), 2019-2024
Table 33. By Country - Europe Recombinant Hirudin Sales, (K Units), 2025-2030
Table 34. By Region - Asia Recombinant Hirudin Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Recombinant Hirudin Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Recombinant Hirudin Sales, (K Units), 2019-2024
Table 37. By Region - Asia Recombinant Hirudin Sales, (K Units), 2025-2030
Table 38. By Country - South America Recombinant Hirudin Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Recombinant Hirudin Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Recombinant Hirudin Sales, (K Units), 2019-2024
Table 41. By Country - South America Recombinant Hirudin Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Recombinant Hirudin Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Recombinant Hirudin Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Recombinant Hirudin Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Recombinant Hirudin Sales, (K Units), 2025-2030
Table 46. Abbott Company Summary
Table 47. Abbott Recombinant Hirudin Product Offerings
Table 48. Abbott Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Abbott Key News & Latest Developments
Table 50. The Medicines Company Company Summary
Table 51. The Medicines Company Recombinant Hirudin Product Offerings
Table 52. The Medicines Company Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. The Medicines Company Key News & Latest Developments
Table 54. Teva Pharmaceutical Company Summary
Table 55. Teva Pharmaceutical Recombinant Hirudin Product Offerings
Table 56. Teva Pharmaceutical Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Teva Pharmaceutical Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Recombinant Hirudin Product Offerings
Table 60. Pfizer Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Pfizer Key News & Latest Developments
Table 62. Pentapharm Company Summary
Table 63. Pentapharm Recombinant Hirudin Product Offerings
Table 64. Pentapharm Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Pentapharm Key News & Latest Developments
Table 66. PrimeGene Company Summary
Table 67. PrimeGene Recombinant Hirudin Product Offerings
Table 68. PrimeGene Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. PrimeGene Key News & Latest Developments
Table 70. Aniara Diagnostica Company Summary
Table 71. Aniara Diagnostica Recombinant Hirudin Product Offerings
Table 72. Aniara Diagnostica Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Aniara Diagnostica Key News & Latest Developments
Table 74. Bioassay Technology Laboratory Company Summary
Table 75. Bioassay Technology Laboratory Recombinant Hirudin Product Offerings
Table 76. Bioassay Technology Laboratory Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Bioassay Technology Laboratory Key News & Latest Developments
Table 78. Novus Biologicals Company Summary
Table 79. Novus Biologicals Recombinant Hirudin Product Offerings
Table 80. Novus Biologicals Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Novus Biologicals Key News & Latest Developments
Table 82. Merck KGaA Company Summary
Table 83. Merck KGaA Recombinant Hirudin Product Offerings
Table 84. Merck KGaA Recombinant Hirudin Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Merck KGaA Key News & Latest Developments
Table 86. Recombinant Hirudin Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Recombinant Hirudin Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Recombinant Hirudin Production by Region, 2019-2024 (K Units)
Table 89. Global Recombinant Hirudin Production by Region, 2025-2030 (K Units)
Table 90. Recombinant Hirudin Market Opportunities & Trends in Global Market
Table 91. Recombinant Hirudin Market Drivers in Global Market
Table 92. Recombinant Hirudin Market Restraints in Global Market
Table 93. Recombinant Hirudin Raw Materials
Table 94. Recombinant Hirudin Raw Materials Suppliers in Global Market
Table 95. Typical Recombinant Hirudin Downstream
Table 96. Recombinant Hirudin Downstream Clients in Global Market
Table 97. Recombinant Hirudin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Hirudin Segment by Type in 2023
Figure 2. Recombinant Hirudin Segment by Application in 2023
Figure 3. Global Recombinant Hirudin Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Recombinant Hirudin Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Hirudin Revenue, 2019-2030 (US$, Mn)
Figure 7. Recombinant Hirudin Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Hirudin Revenue in 2023
Figure 9. By Type - Global Recombinant Hirudin Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 11. By Type - Global Recombinant Hirudin Sales Market Share, 2019-2030
Figure 12. By Type - Global Recombinant Hirudin Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Recombinant Hirudin Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 15. By Application - Global Recombinant Hirudin Sales Market Share, 2019-2030
Figure 16. By Application - Global Recombinant Hirudin Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Recombinant Hirudin Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Recombinant Hirudin Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 20. By Region - Global Recombinant Hirudin Sales Market Share, 2019-2030
Figure 21. By Country - North America Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 22. By Country - North America Recombinant Hirudin Sales Market Share, 2019-2030
Figure 23. US Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Recombinant Hirudin Sales Market Share, 2019-2030
Figure 28. Germany Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 29. France Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Recombinant Hirudin Sales Market Share, 2019-2030
Figure 37. China Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 41. India Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 43. By Country - South America Recombinant Hirudin Sales Market Share, 2019-2030
Figure 44. Brazil Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Recombinant Hirudin Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Recombinant Hirudin Sales Market Share, 2019-2030
Figure 48. Turkey Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Recombinant Hirudin Revenue, (US$, Mn), 2019-2030
Figure 52. Global Recombinant Hirudin Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Recombinant Hirudin by Region, 2023 VS 2030
Figure 54. Recombinant Hirudin Industry Value Chain
Figure 55. Marketing Channels
